Login Register Cart 0
Generic placeholder image

Current Bioinformatics

Editor-in-Chief

ISSN (Print): 1574-8936
ISSN (Online): 2212-392X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Toll-like Receptor 4 Gene Polymorphisms in Chinese Population After Allogeneic Hematopoietic Stem Cell Transplantation

Author(s): Yi Zhao, Yujie Zhang, Jie Zhou, Lijuan Wang, Jimin Shi, Yamin Tan, Yi Luo, He Huang and Zhen Cai*

Volume 16, Issue 2, 2021

Published on: 18 August, 2020

Page: [225 - 229] Pages: 5

DOI: 10.2174/1574893615999200818155048

Price: $65

Abstract

Objectives: Graft-versus-host disease (GVHD) is the most common complication after hematopoietic stem cell transplantation (HSCT) and remains to be a major cause of mortality. Activation of toll-like receptor 4 (TLR-4) by lipopolysaccharide induces the NF-κB signaling pathway to release critical proinflammatory cytokines and increases the recipient response to GVHD. In order to clarify the role of TLR-4 in the occurrence of acute GVHD after HSCT, we collected 208 samples from HSCT recipients and their human lecucyte antigen identical donors to test the hypothesis that TLR-4polymorphism in the recipients or donors influence the risk of acute GVHD in allogeneic HSCT recipients.

Methods: TLR-4 Asp299Gly and Thr399Ile polymorphisms of each sample were examined by using DNA sequencing and polymerase chain reaction-restriction fragment length polymorphism methods.

Results: No homozygous or heterozygous variant alleles of the Asp299Gly or Thr339Ile polymorphism were detected in any samples in our study. Our results demonstrate that TLR-4 Asp299Gly and Thr399Ile polymorphisms might be very rare in the Chinese population (Eastern China and Taiwan region).

Conclusion: The results of this study cannot confirm the role of TLR-4 mutations in the pathogenesis of GVHD in humans, yet we reach a definite conclusion by a TLR-4 knockout murine GVHD model in our ongoing project.

Keywords: Toll-like receptor 4, polymorphisms, graft-versus-host disease, mutation, chinese population, pathogenesis.

« Previous Next »
Graphical Abstract

[1]
Magenau J, Runaas L, Reddy P. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol 2016; 173(2): 190-205.
[http://dx.doi.org/10.1111/bjh.13959] [PMID: 27019012]
[2]
Gartner JG, Durston MM, Booth SA, Ellison CA. Systemic treatment with a miR-146a mimic suppresses endotoxin sensitivity and partially protects mice from the progression of acute graft-versus-host disease. Scand J Immunol 2017; 86(5): 368-76.
[http://dx.doi.org/10.1111/sji.12597] [PMID: 28853768]
[3]
Lu Y, Meng R, Wang X, et al. Author correction: caspase-11 signaling enhances graft-versus-host disease. Nat Commun 2020; 11(1): 1349.
[http://dx.doi.org/10.1038/s41467-020-15161-8] [PMID: 32152304]
[4]
Kramer IM. Activation of the Innate Immune System: The Toll- Like Receptor-4 and Signaling through Ubiquitinylation 2016; pp. 741-5..
[5]
Li M, Zhou Y, Feng G, Su SB. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 2009; 9(3): 365-74.
[http://dx.doi.org/10.2174/156652409787847137] [PMID: 19355917]
[6]
Farrugia M, Baron B. The Role of toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism. Int J Inflamm 2017; 2017, 8391230.
[http://dx.doi.org/10.1155/2017/8391230] [PMID: 28553556]
[7]
Kumar V. Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ Int Immunopharmacol 2018; 59: 391-412. Int Immunopharmacol 2018; 62: 338.
[http://dx.doi.org/10.1016/j.intimp.2018.06.044] [PMID: 30089605]
[8]
Lai JL, Liu YH, Liu C, et al. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflammation 2017; 40(1): 1-12.
[http://dx.doi.org/10.1007/s10753-016-0447-7] [PMID: 27718095]
[9]
Wang X, Zhang L, Duan W, et al. Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model. Mol Med Rep 2014; 10(1): 447-52.
[http://dx.doi.org/10.3892/mmr.2014.2191] [PMID: 24789089]
[10]
Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25(2): 187-91.
[http://dx.doi.org/10.1038/76048] [PMID: 10835634]
[11]
Ferwerda B, McCall MB, Verheijen K, et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 2008; 14(5-6): 346-52.
[http://dx.doi.org/10.2119/2007-00135.Ferwerda] [PMID: 18231573]
[12]
Lorenz E, Schwartz DA, Martin PJ, et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7(7): 384-7.
[http://dx.doi.org/10.1053/bbmt.2001.v7.pm11529488] [PMID: 11529488]
[13]
Zhao Y, Liu Q, Yang L, et al. TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Cell Mol Immunol 2013; 10(2): 165-75.
[http://dx.doi.org/10.1038/cmi.2012.58] [PMID: 23262974]
[14]
Calcaterra C, Sfondrini L, Rossini A, et al. Critical role of TLR9 in acute graft-versus-host disease. J Immunol 2008; 181(9): 6132-9.
[http://dx.doi.org/10.4049/jimmunol.181.9.6132] [PMID: 18941203]
[15]
Mensah NY, Peterlongo P, Steinherz P, Pamer EG, Satagopan J, Papanicolaou GA. Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol Blood Marrow Transplant 2009; 15(9): 1130-3.
[http://dx.doi.org/10.1016/j.bbmt.2009.04.012] [PMID: 19660727]
[16]
Norén E, Verma D, Söderkvist P, et al. Single Nucleotide Polymorphisms in MORC4, CD14, and TLR4 Are Related to Outcome of Allogeneic Stem Cell Transplantation. Ann Transplant 2016; 21: 56-67.
[http://dx.doi.org/10.12659/AOT.895389] [PMID: 26827181]
[17]
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, et al. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms. Blood Adv 2018; 2(14): 1719-37.
[http://dx.doi.org/10.1182/bloodadvances.2017011502] [PMID: 30030270]
[18]
Chien JW, Zhang XC, Fan W, et al. Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood 2012; 119(22): 5311-9.
[http://dx.doi.org/10.1182/blood-2011-09-371153] [PMID: 22282500]
[19]
Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15(6): 825-8.
[PMID: 7581076]
[20]
Long H, O’Connor BP, Zemans RL, Zhou X, Yang IV, Schwartz DA. The Toll-like receptor 4 polymorphism Asp299Gly but not Thr399Ile influences TLR4 signaling and function. PLoS One 2014; 9(4), e93550.
[http://dx.doi.org/10.1371/journal.pone.0093550] [PMID: 24695807]
[21]
Raby BA, Klimecki WT, Laprise C, et al. Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002; 166(11): 1449-56.
[http://dx.doi.org/10.1164/rccm.200207-634OC] [PMID: 12406828]
[22]
Carvalho A, Marques A, Maciel P, Rodrigues F. Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: a novel method applied to the analysis of the Portuguese population. Mol Cell Probes 2007; 21(4): 316-20.
[http://dx.doi.org/10.1016/j.mcp.2007.03.005] [PMID: 17482427]
[23]
Berdeli A, Emingil G, Han Saygan B, et al. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population. J Clin Periodontol 2007; 34(7): 551-7.
[http://dx.doi.org/10.1111/j.1600-051X.2007.01092.x] [PMID: 17555409]
[24]
Nebel A, Flachsbart F, Schäfer A, et al. Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men. Mech Ageing Dev 2007; 128(5-6): 409-11.
[http://dx.doi.org/10.1016/j.mad.2007.04.001] [PMID: 17493663]
[25]
Awomoyi AA, Rallabhandi P, Pollin TI, et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 2007; 179(5): 3171-7.
[http://dx.doi.org/10.4049/jimmunol.179.5.3171] [PMID: 17709532]
[26]
Rezazadeh M, Hajilooi M, Rafiei A, et al. TLR4 polymorphism in Iranian patients with brucellosis. J Infect 2006; 53(3): 206-10.
[http://dx.doi.org/10.1016/j.jinf.2005.10.018] [PMID: 16343635]
[27]
Kim YS, Hwang YJ, Kim SY, Yang SM, Lee KY, Park IeB. Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population. Yonsei Med J 2008; 49(1): 58-62.
[http://dx.doi.org/10.3349/ymj.2008.49.1.58] [PMID: 18306470]
[28]
Zhu H, Fu Z, Gao L, Wang L, Liu E, Tian D. Genetic polymorphisms of toll-like receptor 4 are associated with respiratory syncytial virus infection in a Chinese infant population. Clin Lab 2015; 61(10): 1391-9.
[http://dx.doi.org/10.7754/Clin.Lab.2015.150145] [PMID: 26642699]
[29]
Yuan M, Xia J, Ma L, Xiao B, Yang Q. Lack of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399ile in a Chinese population. Int J Neurosci 2010; 120(6): 415-20.
[http://dx.doi.org/10.3109/00207451003778736] [PMID: 20504212]
[30]
Aki K, Okubo Y, Nanjo H, et al. Genomic analysis of single nucleotide polymorphisms Asp299Gly and Thr399Ile in Japanese patients with invasive Aspergillosis. Jpn J Infect Dis 2015; 68(4): 330-2.
[http://dx.doi.org/10.7883/yoken.JJID.2014.420] [PMID: 25766605]
[31]
Shi G, Wang T, Li S, et al. TLR2 and TLR4 polymorphisms in Southern Chinese psoriasis vulgaris patients. J Dermatol Sci 2016; 83(2): 145-7.
[http://dx.doi.org/10.1016/j.jdermsci.2016.04.014] [PMID: 27155792]
[32]
Lin Y, Gao ZX, Shen X, et al. Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population. BMC Infect Dis 2018; 18(1): 28.
[http://dx.doi.org/10.1186/s12879-018-2943-x] [PMID: 29320990]

Rights & Permissions Print Cite
Article Metrics
33
1
© 2024 Bentham Science Publishers | Privacy Policy